New variants and in silico analyses in GRK1 associated Oguchi disease.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
02 2021
Historique:
received: 26 03 2020
revised: 15 09 2020
accepted: 05 11 2020
pubmed: 1 12 2020
medline: 1 4 2022
entrez: 30 11 2020
Statut: ppublish

Résumé

Biallelic mutations in G-Protein coupled receptor kinase 1 (GRK1) cause Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB). The purpose of this study was to identify disease causing GRK1 variants and use in-depth bioinformatic analyses to evaluate how their impact on protein structure could lead to pathogenicity. Patients' genomic DNA was sequenced by whole genome, whole exome or focused exome sequencing. Disease associated variants, published and novel, were compared to nondisease associated missense variants. The impact of GRK1 missense variants at the protein level were then predicted using a series of computational tools. We identified twelve previously unpublished cases with biallelic disease associated GRK1 variants, including eight novel variants, and reviewed all GRK1 disease associated variants. Further structure-based scoring revealed a hotspot for missense variants in the kinase domain. In addition, to aid future clinical interpretation, we identified the bioinformatics tools best able to differentiate disease associated from nondisease associated variants. We identified GRK1 variants in Oguchi disease patients and investigated how disease-causing variants may impede protein function in-silico.

Identifiants

pubmed: 33252155
doi: 10.1002/humu.24140
pmc: PMC7898643
doi:

Substances chimiques

G-Protein-Coupled Receptor Kinase 1 EC 2.7.11.14
GRK1 protein, human EC 2.7.11.14

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-176

Subventions

Organisme : Medical Research Council
ID : MC_EX_MR/M009203/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024952/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009203/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 205041/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_14089
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Human Mutation published by Wiley Periodicals LLC.

Références

Am J Ophthalmol. 2007 Sep;144(3):475-7
pubmed: 17765441
FEBS Lett. 1972 Jan 15;20(1):1-6
pubmed: 11946367
Nucleic Acids Res. 2017 Jul 3;45(W1):W229-W235
pubmed: 28525590
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2824-7
pubmed: 9501174
Nucleic Acids Res. 2019 Jan 8;47(D1):D351-D360
pubmed: 30398656
Biochemistry. 2011 Mar 22;50(11):1940-9
pubmed: 21265573
J Med Genet. 2014 Mar;51(3):143-51
pubmed: 24401286
Protein Sci. 2020 Jan;29(1):111-119
pubmed: 31606900
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
EMBO J. 1998 Jun 15;17(12):3484-94
pubmed: 9628884
Ophthalmology. 2007 Jan;114(1):134-41
pubmed: 17070587
J Biol Chem. 1997 Jul 18;272(29):18125-31
pubmed: 9218446
Physiol Rev. 2015 Apr;95(2):377-404
pubmed: 25834229
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2218-2238
pubmed: 28418496
Genet Med. 2017 Oct;19(10):1151-1158
pubmed: 28518168
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
Annu Rev Biochem. 1998;67:653-92
pubmed: 9759500
Nat Genet. 1997 Feb;15(2):175-8
pubmed: 9020843
Ophthalmology. 2019 Nov;126(11):1557-1566
pubmed: 31257036
Hum Mutat. 2021 Feb;42(2):164-176
pubmed: 33252155
Jpn J Ophthalmol. 1996;40(4):511-9
pubmed: 9130055
Klin Oczna. 2015;117(1):27-30
pubmed: 26349155
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7
pubmed: 22689647
Proc Natl Acad Sci U S A. 1986 Mar;83(5):1174-8
pubmed: 3006038
J Biol Chem. 2006 Jun 16;281(24):16785-93
pubmed: 16613860
Am J Ophthalmol. 2012 Dec;154(6):987-1001.e1
pubmed: 22959359
Mol Vis. 2009 Sep 05;15:1788-93
pubmed: 19753316
Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):328-33
pubmed: 9419375
Am J Hum Genet. 2017 Jun 1;100(6):960-968
pubmed: 28575650
Cell Signal. 2018 Jan;41:17-24
pubmed: 28711719
Mol Vis. 2005 Nov 14;11:977-85
pubmed: 16319817
Biochim Biophys Acta. 2013 Jul;1834(7):1302-21
pubmed: 23524293
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Curr Opin Cell Biol. 2014 Apr;27:25-31
pubmed: 24680427
Sci Rep. 2019 Feb 4;9(1):1219
pubmed: 30718709
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8857-62
pubmed: 17496142
JAMA Ophthalmol. 2017 Apr 1;135(4):339-347
pubmed: 28253385
Cell Res. 2017 Jun;27(6):728-747
pubmed: 28524165
Ophthalmic Genet. 2018 Jan-Feb;39(1):137-138
pubmed: 28511019
Mol Med Rep. 2016 Oct;14(4):3129-33
pubmed: 27511724

Auteurs

James A Poulter (JA)

Division of Molecular Medicine, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.

Molly S C Gravett (MSC)

School of Molecular and Cellular Biology, University of Leeds, Leeds, UK.

Rachel L Taylor (RL)

Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, UK.

Kaoru Fujinami (K)

National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Centre, Tokyo, Japan.
Moorfields Eye Hospital, London, UK.
UCL Institute of Ophthalmology, London, UK.
Keio University School of Medicine, Tokyo, Japan.

Julie De Zaeytijd (J)

Ghent University, Ghent, Belgium.

James Bellingham (J)

UCL Institute of Ophthalmology, London, UK.

Atta Ur Rehman (AU)

Division of Genetic Medicine, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Lausanne, Switzerland.

Takaaki Hayashi (T)

The Jikei University School of Medicine, Tokyo, Japan.

Mineo Kondo (M)

Mie University Graduate School of Medicine, Mie, Japan.

Abdur Rehman (A)

Department of Genetics, Faculty of Science, Hazara University Mansehra, Dhodial, Pakistan.

Muhammad Ansar (M)

Clinical Research Center, Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.

Dan Donnelly (D)

School of Biomedical Sciences, University of Leeds, Leeds, UK.

Carmel Toomes (C)

Division of Molecular Medicine, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.

Manir Ali (M)

Division of Molecular Medicine, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.

Elfride De Baere (E)

Ghent University, Ghent, Belgium.

Bart P Leroy (BP)

Ghent University, Ghent, Belgium.
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Nigel P Davies (NP)

St Thomas's Hospital, London, UK.

Robert H Henderson (RH)

Department of Ophthalmology, Great Ormond Street Hospital, London, UK.

Andrew R Webster (AR)

Moorfields Eye Hospital, London, UK.
UCL Institute of Ophthalmology, London, UK.

Carlo Rivolta (C)

Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.
Clinical Research Center, Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.

Christina Zeitz (C)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.

Omar A Mahroo (OA)

Moorfields Eye Hospital, London, UK.
UCL Institute of Ophthalmology, London, UK.

Gavin Arno (G)

National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Centre, Tokyo, Japan.
Moorfields Eye Hospital, London, UK.
UCL Institute of Ophthalmology, London, UK.

Graeme C M Black (GCM)

Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, UK.
Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Martin McKibbin (M)

Division of Molecular Medicine, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
Leeds Teaching Hospitals NHS Trust, St James' University Hospital, Leeds, UK.

Sarah A Harris (SA)

School of Physics and Astronomy, University of Leeds, Leeds, UK.

Kamron N Khan (KN)

Division of Molecular Medicine, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Chris F Inglehearn (CF)

Division of Molecular Medicine, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH